Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Chemotherapy of respiratory syncytial virus infections: the final breakthrough — De Clercq Erik (2015) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Chemotherapy of respiratory syncytial virus infections: the final breakthrough
Shared by
De Clercq Erik
KU Leuven
Chemotherapy of respiratory syncytial virus infections: the final breakthrough
Article
2015
en
Related publications
Article
1996
Perspectives for the chemotherapy of respiratory syncytial virus (RSV) infections
De Clercq Erik
Article
1994
Chemotherapy of varicella zoster virus infections
Robert Snoeck
,
Graciela Andreï
,
De Clercq Erik
Authors
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Article
1987
Inhibitory effects of antiviral compounds on respiratory syncytial virus replication in vitro
Fuyuhiko Kawana
,
Shirô Shigeta
,
Mitsuaki Hosoya
,
Hitoshi Suzuki
,
De Clercq Erik
Article
1985
Inhibitory effects of several antiviral compounds on the replication of respiratory syncytial virus in vitro
Fuyuhiko Kawana
,
Shirô Shigeta
,
De Clercq Erik
Letter
2025
Assessing monoclonal antibodies for respiratory virus infections
Sir Nicholas White
,
William HK Schilling
,
Podjanee Jittamala
,
Phrutsamon Wongnak
,
James A Watson
Discussion(0)
No comments yet. Be the first to comment.